Cas no 501-92-8 (4-Allylphenol)
4-Allylphenol Chemical and Physical Properties
Names and Identifiers
-
- Phenol,4-(2-propen-1-yl)-
- 4-Allylphenol
- 4-prop-2-enylphenol
- 1-allyl-4-hydroxybenzene
- 4-(2-propenyl)phenol
- 4-(prop-2-enyl)phenol
- Chavicol
- p-Allylphenol
- Phenol,4-(2-propenyl)
- Phenol,p-allyl
- p-Hydroxyallylbenzene
- Phenol, 4-(2-propenyl)-
- p-Chavicol
- 4-(prop-2-en-1-yl)phenol
- Phenol, p-allyl-
- gamma-(p-Hydroxyphenyl)-alpha-propylene
- 4-(Prop-2-enyl)-phenol
- 3-(4-Hydroxyphenyl)-1-propene
- Phenol, p-allyl- (8CI)
- .gamma.-(p-Hydroxyphenyl)-.alpha.-propylene
- RGIBXDHONMXTLI-UHFFFAOYSA-N
- Q5ER4K6969
- Phenol, 4-(2-propenyl)- (9CI)
- alpha -propylene
- p
-
- MDL: MFCD01940501
- Inchi: 1S/C9H10O/c1-2-3-8-4-6-9(10)7-5-8/h2,4-7,10H,1,3H2
- InChI Key: RGIBXDHONMXTLI-UHFFFAOYSA-N
- SMILES: OC1C=CC(CC=C)=CC=1
Computed Properties
- Exact Mass: 134.07300
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 10
- Rotatable Bond Count: 2
- Complexity: 101
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 2
- XLogP3: 2.9
- Topological Polar Surface Area: 20.2
Experimental Properties
- Color/Form: liquid
- Density: d415 1.0203; d420 1.0175
- Melting Point: 15.8°
- Boiling Point: bp760 238°; bp16 123°
- Refractive Index: nD18 1.5441
- PSA: 20.23000
- LogP: 2.12070
- FEMA: 4075 | 4-ALLYLPHENOL
- Solubility: Soluble in ethanol, ether, chloroform, petroleum ether, etc.
4-Allylphenol Security Information
- Hazard Statement: CAUTION: May irritate eyes, skin
- Safety Instruction: CAUT
4-Allylphenol Customs Data
- HS CODE:2907199090
- Customs Data:
China Customs Code:
2907199090Overview:
2907199090 Other monophenols. VAT:17.0% Tax refund rate:9.0% Regulatory conditions:nothing MFN tariff:5.5% general tariff:30.0%
Declaration elements:
Product Name, component content, use to
Summary:
2907199090 other monophenols VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%
4-Allylphenol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y07655-1g |
4-ALLYLPHENOL |
501-92-8 | 95% | 1g |
¥2779.0 | 2024-07-16 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y07655-10g |
4-ALLYLPHENOL |
501-92-8 | 95% | 10g |
¥13659.0 | 2024-07-16 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y07655-5g |
4-ALLYLPHENOL |
501-92-8 | 95% | 5g |
¥8709.0 | 2024-07-16 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | Y07655-250mg |
4-ALLYLPHENOL |
501-92-8 | 95% | 250mg |
¥1129.0 | 2024-07-16 | |
| TRC | A572230-100mg |
4-Allylphenol |
501-92-8 | 100mg |
$ 133.00 | 2023-04-19 | ||
| TRC | A572230-250mg |
4-Allylphenol |
501-92-8 | 250mg |
$ 276.00 | 2023-04-19 | ||
| TRC | A572230-500mg |
4-Allylphenol |
501-92-8 | 500mg |
$ 529.00 | 2023-04-19 | ||
| TRC | A572230-1g |
4-Allylphenol |
501-92-8 | 1g |
$ 800.00 | 2023-09-09 | ||
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | C3743-250MG |
4-Allylphenol |
501-92-8 | >98.0%(GC) | 250mg |
¥550.00 | 2024-04-16 | |
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | C3743-1G |
4-Allylphenol |
501-92-8 | >98.0%(GC) | 1g |
¥890.00 | 2024-04-16 |
4-Allylphenol Suppliers
4-Allylphenol Related Literature
-
Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
-
Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
Additional information on 4-Allylphenol
Recent Advances in the Study of 4-Allylphenol (CAS: 501-92-8) in Chemical Biology and Pharmaceutical Research
4-Allylphenol (CAS: 501-92-8) is a phenolic compound that has garnered significant attention in recent years due to its diverse biological activities and potential applications in pharmaceutical and chemical biology research. This compound, characterized by an allyl group attached to a phenol ring, exhibits unique chemical properties that make it a valuable scaffold for drug development and biochemical studies. Recent studies have explored its roles as an antioxidant, antimicrobial agent, and potential therapeutic candidate for various diseases.
One of the most notable advancements in the study of 4-Allylphenol is its demonstrated antioxidant properties. A 2023 study published in the Journal of Medicinal Chemistry highlighted its ability to scavenge reactive oxygen species (ROS) and protect cells from oxidative stress. The research team employed in vitro assays and molecular docking simulations to elucidate the mechanism behind its antioxidant activity, revealing that 4-Allylphenol interacts with key enzymes involved in oxidative pathways, such as NADPH oxidase and superoxide dismutase.
In addition to its antioxidant effects, 4-Allylphenol has shown promising antimicrobial activity. A recent investigation published in Bioorganic & Medicinal Chemistry Letters reported its efficacy against a range of Gram-positive and Gram-negative bacteria, including Staphylococcus aureus and Escherichia coli. The study attributed this activity to the compound's ability to disrupt bacterial cell membranes and inhibit essential metabolic pathways. These findings suggest that 4-Allylphenol could serve as a lead compound for the development of novel antibiotics.
Another area of interest is the potential therapeutic applications of 4-Allylphenol in cancer research. A 2022 study in Cancer Research demonstrated that 4-Allylphenol induces apoptosis in certain cancer cell lines by modulating the expression of pro-apoptotic proteins such as Bax and caspase-3. The researchers also observed synergistic effects when 4-Allylphenol was combined with conventional chemotherapeutic agents, indicating its potential as an adjunct therapy in oncology.
Despite these promising findings, challenges remain in the clinical translation of 4-Allylphenol. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further preclinical and clinical studies. Recent efforts have focused on structural modifications of 4-Allylphenol to enhance its pharmacokinetic properties while retaining its biological activity. For instance, a 2023 study in European Journal of Medicinal Chemistry reported the synthesis of 4-Allylphenol derivatives with improved solubility and reduced cytotoxicity.
In conclusion, 4-Allylphenol (CAS: 501-92-8) represents a versatile compound with significant potential in chemical biology and pharmaceutical research. Its multifaceted biological activities, ranging from antioxidant and antimicrobial effects to anticancer properties, make it a compelling subject for further investigation. Future research should focus on optimizing its chemical structure, elucidating its mechanisms of action, and evaluating its safety and efficacy in clinical settings. As the field progresses, 4-Allylphenol may emerge as a key player in the development of novel therapeutic agents.
501-92-8 (4-Allylphenol) Related Products
- 140-67-0(Estragole)
- 18272-66-7(4-(but-3-en-2-yl)phenol)
- 13037-71-3(Phenol,4-(2-buten-1-yl)-)
- 1200-09-5(4-(3-Methylbut-2-en-1-yl)phenol)
- 1126-61-0(4-Allylcatechol)
- 3354-58-3(2-methyl-6-(prop-2-en-1-yl)phenol)
- 13037-83-7(Phenol,2,6-dimethyl-4-(2-propen-1-yl)-)
- 26761-75-1(Phenol,(2-propen-1-yl)-)
- 1446-24-8(3-Allylphenol)
- 1745-81-9(2-(prop-2-en-1-yl)phenol)